Market by Phase Type, Service, Sponsor, and Regional Outlook | Forecast 2022-2028
Services that aid in
optimizing the process of conducting clinical trials are known as clinical
trial support services. Support services help speed up the trial process by
managing data and analyzing it. There is a rise in the prevalence of infectious
and tropical diseases, especially in developing nations. The numerous unmet needs
of patients call for the development of novel drugs for disease treatment,
which necessitates carrying out clinical trials. Also, the exposure to new
diseases like COVID-19 and monkeypox has increased the demand for vaccines. All
of these requirements have created opportunities for businesses to provide
support services in order to maintain the massive amounts of data.
According to Triton Market Research’s report, the Global Clinical Trials Support Services Market is likely to reach $34994.75 million by 2028, from $20677.01 million in 2021, with a CAGR of 7.84% during the forecast period 2022-2028.
Click here to check out our blog on the Global Clinical Trials Support Services Market
MARKET PERFORMANCE: DRIVERS, CHALLENGES, AND TRENDS
Over
the forecast period, the market expansion is likely to be fueled by the rising
disease incidence and the effectiveness of support services in overcoming the
barriers encountered while conducting clinical trials.
For instance, the costs associated with conducting clinical trials are
increasing, which has become a significant challenge. Other difficulties associated
with performing clinical trials include complexity, time required, and risk
management. Contract research organizations (CROs) have developed a variety of
solutions to address these issues in order to make the process more effective
and worthwhile. These solutions include site selection & recruitment,
clinical trial site management, data management, and others.
However,
the disadvantages of open-source software and delays in receiving approvals due
to stringent regulatory frameworks are factors hindering the market growth.
Clinical trials are a crucial step in the development of new medical products. And
before initiating these trials for a larger patient population, it is necessary
to seek approval from regulatory bodies. The guidelines issued by regulatory authorities
demand that medical products are efficient and safe for human consumption,
among other requirements. Sometimes, ensuring that companies and research institutions
meet all the requirements consumes a significant amount of time-intensive. This
delays the approval of clinical trials, thus impacting the entire process of
testing the medical product.
The rise in screening tests presents an overall positive outlook for the market. The number of patients has increased over time. For instance, globally, prevalent cases of total cardiovascular diseases nearly doubled, from 271 million in 1990 to 523 million in 2019. As a result, the need for developing effective treatments also increased. The number of clinical trials conducted has also increased due to this, which has led to more screening tests being performed prior to including patients in trials. The use of screening tests to determine whether prospective subjects are suitable candidates for inclusion in trials is an appropriate pre-entry activity for some studies.
KEY GEOGRAPHIES COVERED:
• North America: United States and Canada
• Europe: United Kingdom, France,
Germany, Spain, Italy, and Rest of Europe
• Asia-Pacific: China, Japan, India,
Australia, New Zealand, South Korea, ASEAN Countries, and Rest of Asia Pacific
• Latin America: Brazil, Mexico, and Rest
of Latin America
• Middle East and Africa: Saudi Arabia,
Turkey, United Arab Emirates, South Africa, and Rest of Middle East &
Africa
SEGMENTATION ANALYSIS – CLINICAL TRIALS SUPPORT SERVICES MARKET:
• Market by
Phase Type:
o Phase I
o Phase II
o Phase III
o Phase IV
Phase
I is expected to be the fastest-growing phase type, with a CAGR of 9.32%.
Clinical trials begin with a phase I trial, which verifies that they are safe
to conduct on people. This phase assesses the distribution of the drug or
vaccine throughout the body. Only a small group of healthy people participate voluntarily.
The study’s initial participants receive a very small dose of the medication
and are closely monitored. The subsequent participants will receive a dose that
is higher if there are only minor side effects.
• Market by
Service:
o Clinical Trial Site Management
o Administrative Staff
o Patient Recruitment Management
o Institutional Review Board (IRB)
o Data Management
o Other Services
Clinical
trial site management is the largest service, which accounted for the highest
revenue share of $9124.68 million in 2021.
Conducting a clinical trial is a massive and difficult task. A clinical trial
necessitates the participation of thousands, if not millions, of people –
patients, doctors, researchers, and so on. It also entails collecting a large
amount of data that must be stored and secured. This data is critical and must
be kept up to date on a regular basis. Also, such sensitive data cannot be
handled manually, which is where clinical trial management software comes in.
Because of advances in technology, the process of conducting clinical trials has
become more streamlined.
• Market by Sponsor:
o Pharmaceutical & Biopharmaceutical
Companies
o Medical Device Companies
o Other Sponsors
COMPETITIVE LANDSCAPE:
The competitive
landscape helps dive into data about the key players in the clinical trials
support services market. The strategic initiatives for each of the companies
considered have been covered in detail.
Acquisition
(February 2021): ICON Plc and PRA Health Sciences
PRA Health Sciences, a
contract research organization that develops drugs and provides clinical
development services, was acquired by ICON Plc.
Investments
& Expansions (February 2021): KCR
KCR established a new
branch in Sydney, Australia. The new location will widen KCR’s regional
coverage while also increasing clinical capabilities for clients worldwide.
KEY BENEFITS OF THE REPORT:
· Triton Market Research has a collective experience of 25-30 years in the industry, with its analysts and experts encompassing the most infallible research methodology for its market intelligence and industry analysis.
· Our research methodology helps in achieving a broader consensus of the market size, shape, and industry trends within each industry segment.
· The strategy adopted in designing the research methodology includes the amalgamation of the information assembled from primary and secondary sources, with the assistance of analytical tools to construct the forecast and predictive models.
·
The scope of the market report
comprises the current scenario of the global clinical trials support services
market, along with the detailed overview of the industry outlook, market
dynamics, segmentation analysis, regional outlook, and competitive landscape
for the period 2022-2028.
FAQs:
Q 1) Does this report include the impact of COVID-19 on the
clinical trials support services market?
The market study has
analyzed the impact of COVID-19 on the clinical trial support services market
qualitatively as well as quantitatively.
Q 2) Which region held the largest market share in 2021?
The majority of the market
share was held by North America in 2021, with $8200.15 million in revenue.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT1. GLOBAL
CLINICAL TRIALS SUPPORT SERVICES MARKET – SUMMARY
2. INDUSTRY
OUTLOOK
2.1. IMPACT
OF COVID-19 ON THE CLINICAL TRIALS SUPPORT SERVICES MARKET
2.2. KEY
INSIGHTS
2.2.1. KEY
PLAYERS’ PROMISING COLLABORATIONS
2.2.2. INCREASE
IN SCREENING TESTS
2.3. PORTER’S
FIVE FORCES ANALYSIS
2.3.1. THREAT
OF NEW ENTRANTS
2.3.2. THREAT
OF SUBSTITUTES
2.3.3. BARGAINING
POWER OF BUYERS
2.3.4. BARGAINING
POWER OF SUPPLIERS
2.3.5. THREAT
OF COMPETITIVE RIVALRY
2.4. KEY
BUYING IMPACT ANALYSIS
2.4.1. PERFORMANCE
2.4.2. EASE
OF USE
2.4.3. SECURITY
2.4.4. COST
EFFECTIVENESS
2.5. MARKET
ATTRACTIVENESS INDEX
2.6. VENDOR
SCORECARD
2.7. INDUSTRY
COMPONENTS
2.8. REGULATORY
FRAMEWORK
2.9. KEY
MARKET STRATEGIES
2.9.1. ACQUISITIONS
2.9.2. PRODUCT
LAUNCHES
2.9.3. CONTRACTS
& AGREEMENTS
2.9.4. INVESTMENTS
& EXPANSIONS
2.10. MARKET
DRIVERS
2.10.1. NEED
TO OVERCOME THE BARRIERS IN CLINICAL TRIALS
2.10.2. RISE
IN TRIALS DUE TO INCREASED DISEASE INCIDENCE
2.11. MARKET
CHALLENGES
2.11.1. DELAYED
APPROVAL DUE TO STRINGENT REGULATORY FRAMEWORK
2.11.2. USE OF
OPEN-SOURCE SOFTWARE
2.12. MARKET
OPPORTUNITIES
2.12.1. INCREASING
DEMAND FOR VACCINES AND PHARMACEUTICALS
2.12.2. DATA
MANAGEMENT SERVICE EXPECTED TO WITNESS NOTABLE GROWTH
2.12.3. ACQUISITIONS
IN THE CLINICAL TRIALS SUPPORT SERVICES MARKET
3. GLOBAL
CLINICAL TRIALS SUPPORT SERVICES MARKET OUTLOOK – BY PHASE TYPE
3.1. PHASE
I
3.2. PHASE
II
3.3. PHASE
III
3.4. PHASE
IV
4. GLOBAL
CLINICAL TRIALS SUPPORT SERVICES MARKET OUTLOOK – BY SERVICE
4.1. CLINICAL
TRIAL SITE MANAGEMENT
4.2. ADMINISTRATIVE
SERVICES
4.3. PATIENT
RECRUITMENT MANAGEMENT
4.4. REGULATORY
SERVICES
4.5. DATA
MANAGEMENT
4.6. OTHER
SERVICES
5. GLOBAL
CLINICAL TRIALS SUPPORT SERVICES MARKET OUTLOOK – BY SPONSOR
5.1. PHARMACEUTICAL
& BIOPHARMACEUTICAL COMPANIES
5.2. MEDICAL
DEVICE COMPANIES
5.3. OTHER
SPONSORS
6. GLOBAL
CLINICAL TRIALS SUPPORT SERVICES MARKET – REGIONAL OUTLOOK
6.1. NORTH
AMERICA
6.1.1. MARKET
OUTLOOK BY SERVICE
6.1.2. MARKET
OUTLOOK BY PHASE TYPE
6.1.3. MARKET
OUTLOOK BY SPONSOR
6.1.4. COUNTRY
ANALYSIS
6.1.4.1. UNITED
STATES
6.1.4.2. CANADA
6.2. EUROPE
6.2.1. MARKET
OUTLOOK BY SERVICE
6.2.2. MARKET
OUTLOOK BY PHASE TYPE
6.2.3. MARKET
OUTLOOK BY SPONSOR
6.2.4. COUNTRY
ANALYSIS
6.2.4.1. UNITED
KINGDOM
6.2.4.2. GERMANY
6.2.4.3. FRANCE
6.2.4.4. SPAIN
6.2.4.5. ITALY
6.2.4.6. REST
OF EUROPE
6.3. ASIA-PACIFIC
6.3.1. MARKET
OUTLOOK BY SERVICE
6.3.2. MARKET
OUTLOOK BY PHASE TYPE
6.3.3. MARKET
OUTLOOK BY SPONSOR
6.3.4. COUNTRY
ANALYSIS
6.3.4.1. CHINA
6.3.4.2. JAPAN
6.3.4.3. INDIA
6.3.4.4. SOUTH
KOREA
6.3.4.5. ASEAN
COUNTRIES
6.3.4.6. AUSTRALIA
& NEW ZEALAND
6.3.4.7. REST
OF ASIA-PACIFIC
6.4. LATIN
AMERICA
6.4.1. MARKET
OUTLOOK BY SERVICE
6.4.2. MARKET
OUTLOOK BY PHASE TYPE
6.4.3. MARKET
OUTLOOK BY SPONSOR
6.4.4. COUNTRY
ANALYSIS
6.4.4.1. BRAZIL
6.4.4.2. MEXICO
6.4.4.3. REST
OF LATIN AMERICA
6.5. MIDDLE
EAST AND AFRICA
6.5.1. MARKET
OUTLOOK BY SERVICE
6.5.2. MARKET
OUTLOOK BY PHASE TYPE
6.5.3. MARKET
OUTLOOK BY SPONSOR
6.5.4. COUNTRY
ANALYSIS
6.5.4.1. UNITED
ARAB EMIRATES
6.5.4.2. SAUDI
ARABIA
6.5.4.3. TURKEY
6.5.4.4. SOUTH
AFRICA
6.5.4.5. REST
OF MIDDLE EAST & AFRICA
7. COMPETITIVE
LANDSCAPE
7.1. IQVIA
7.2. PAREXEL
7.3. ICON
PLC
7.4. SYNEOS
HEALTH
7.5. LABCORP
DRUG DEVELOPMENT
7.6. CLINIPACE
7.7. KCR
7.8. CHARLES
RIVER LABORATORIES
7.9. MEDPACE
7.10. ALCURA
7.11. PSI
CRO
7.12. WORLDWIDE
CLINICAL TRIALS
7.13. CTI
CLINICAL TRIAL AND CONSULTING SERVICES INC
7.14. WUXI
APPTEC
7.15. ADVANCED
CLINICAL
8. RESEARCH
METHODOLOGY & SCOPE
8.1. RESEARCH
SCOPE & DELIVERABLES
8.2. SOURCES
OF DATA
8.3. RESEARCH
METHODOLOGY
TABLE
1: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, REGIONAL OUTLOOK, 2022-2028
(IN $ MILLION)
TABLE
2: LIST OF COLLABORATIONS
TABLE
3: VENDOR SCORECARD
TABLE
4: REGULATORY FRAMEWORK
TABLE
5: LIST OF ACQUISITIONS
TABLE
6: LIST OF PRODUCT LAUNCHES
TABLE
7: LIST OF CONTRACTS & AGREEMENTS
TABLE
8: LIST OF INVESTMENTS & BUSINESS EXPANSIONS
TABLE
9: LIST OF PANDEMIC OUTBREAKS
TABLE
10: LIST OF OPEN-SOURCE SOFTWARE
TABLE
11: LAUNCH OF MEDICAL DRUGS
TABLE
12: PROMISING ACQUISITIONS IN THE MARKET
TABLE
13: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE TYPE, 2022-2028
(IN $ MILLION)
TABLE
14: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY SERVICE, 2022-2028 (IN $
MILLION)
TABLE
15: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY SPONSOR, 2022-2028 (IN $
MILLION)
TABLE
16: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, REGIONAL OUTLOOK, 2022-2028
(IN $ MILLION)
TABLE
17: NORTH AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY SERVICE,
2022-2028 (IN $ MILLION)
TABLE
18: NORTH AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE TYPE,
2022-2028 (IN $ MILLION)
TABLE
19: NORTH AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY SPONSOR,
2022-2028 (IN $ MILLION)
TABLE
20: NORTH AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET, COUNTRY OUTLOOK,
2022-2028 (IN $ MILLION)
TABLE
21: NUMBER AND TYPES OF REGISTERED STUDIES
TABLE
22: EUROPE CLINICAL TRIALS SUPPORT SERVICES MARKET, BY SERVICE, 2022-2028 (IN $
MILLION)
TABLE
23: EUROPE CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE TYPE, 2022-2028
(IN $ MILLION)
TABLE
24: EUROPE CLINICAL TRIALS SUPPORT SERVICES MARKET, BY SPONSOR, 2022-2028 (IN $
MILLION)
TABLE
25: EUROPE CLINICAL TRIALS SUPPORT SERVICES MARKET, COUNTRY OUTLOOK, 2022-2028
(IN $ MILLION)
TABLE
26: ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, BY SERVICE, 2022-2028
(IN $ MILLION)
TABLE
27: ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE TYPE,
2022-2028 (IN $ MILLION)
TABLE
28: ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, BY SPONSOR, 2022-2028
(IN $ MILLION)
TABLE
29: ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, COUNTRY OUTLOOK,
2022-2028 (IN $ MILLION)
TABLE
30: LATIN AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY SERVICE,
2022-2028 (IN $ MILLION)
TABLE
31: LATIN AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE TYPE,
2022-2028 (IN $ MILLION)
TABLE
32: LATIN AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY SPONSOR,
2022-2028 (IN $ MILLION)
TABLE
33: LATIN AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET, COUNTRY OUTLOOK,
2022-2028 (IN $ MILLION)
TABLE
34: MIDDLE EAST AND AFRICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY SERVICE,
2022-2028 (IN $ MILLION)
TABLE
35: MIDDLE EAST AND AFRICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE
TYPE, 2022-2028 (IN $ MILLION)
TABLE
36: MIDDLE EAST AND AFRICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY SPONSOR,
2022-2028 (IN $ MILLION)
TABLE
37: MIDDLE EAST AND AFRICA CLINICAL TRIALS SUPPORT SERVICES MARKET, COUNTRY
OUTLOOK, 2022-2028 (IN $ MILLION)
FIGURE
1: KEY BUYING IMPACT ANALYSIS
FIGURE
2: MARKET ATTRACTIVENESS INDEX
FIGURE
3: INDUSTRY COMPONENTS
FIGURE
4: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE TYPE, 2021 &
2028 (IN %)
FIGURE
5: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE I, 2022-2028 (IN $
MILLION)
FIGURE
6: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE II, 2022-2028 (IN $
MILLION)
FIGURE
7: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE III, 2022-2028 (IN
$ MILLION)
FIGURE
8: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE IV, 2022-2028 (IN $
MILLION)
FIGURE
9: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY SERVICE, 2021 & 2028
(IN %)
FIGURE
10: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY CLINICAL TRIAL SITE
MANAGEMENT, 2022-2028 (IN $ MILLION)
FIGURE
11: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY ADMINISTRATIVE SERVICES,
2022-2028 (IN $ MILLION)
FIGURE
12: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PATIENT RECRUITMENT
MANAGEMENT, 2022-2028 (IN $ MILLION)
FIGURE
13: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY REGULATORY SERVICES,
2022-2028 (IN $ MILLION)
FIGURE
14: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY DATA MANAGEMENT,
2022-2028 (IN $ MILLION)
FIGURE
15: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY OTHER SERVICES,
2022-2028 (IN $ MILLION)
FIGURE
16: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY SPONSOR, 2021 & 2028
(IN %)
FIGURE
17: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHARMACEUTICAL &
BIOPHARMACEUTICAL COMPANIES, 2022-2028 (IN $ MILLION)
FIGURE
18: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY MEDICAL DEVICE
COMPANIES, 2022-2028 (IN $ MILLION)
FIGURE
19: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY OTHER SPONSORS,
2022-2028 (IN $ MILLION)
FIGURE
20: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, REGIONAL OUTLOOK, 2021
& 2028 (IN %)
FIGURE
21: NORTH AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET, COUNTRY OUTLOOK,
2021 & 2028 (IN %)
FIGURE
22: UNITED STATES CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028 (IN $
MILLION)
FIGURE
23: CANADA CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028 (IN $ MILLION)
FIGURE
24: EUROPE CLINICAL TRIALS SUPPORT SERVICES MARKET, COUNTRY OUTLOOK, 2021 &
2028 (IN %)
FIGURE
25: UNITED KINGDOM CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028 (IN $
MILLION)
FIGURE
26: GERMANY CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028 (IN $ MILLION)
FIGURE
27: FRANCE CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028 (IN $ MILLION)
FIGURE
28: SPAIN CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028 (IN $ MILLION)
FIGURE
29: ITALY CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028 (IN $ MILLION)
FIGURE
30: REST OF EUROPE CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028 (IN $
MILLION)
FIGURE
31: ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, COUNTRY OUTLOOK, 2021
& 2028 (IN %)
FIGURE
32: CHINA CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028 (IN $ MILLION)
FIGURE
33: JAPAN CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028 (IN $ MILLION)
FIGURE
34: INDIA CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028 (IN $ MILLION)
FIGURE
35: SOUTH KOREA CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028 (IN $
MILLION)
FIGURE
36: ASEAN COUNTRIES CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028 (IN $
MILLION)
FIGURE
37: AUSTRALIA & NEW ZEALAND CLINICAL TRIALS SUPPORT SERVICES MARKET
2022-2028 (IN $ MILLION)
FIGURE
38: REST OF ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028 (IN
$ MILLION)
FIGURE
39: LATIN AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET, COUNTRY OUTLOOK,
2021 & 2028 (IN %)
FIGURE
40: BRAZIL CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028 (IN $ MILLION)
FIGURE
41: MEXICO CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028 (IN $ MILLION)
FIGURE
42: REST OF LATIN AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028 (IN
$ MILLION)
FIGURE
43: MIDDLE EAST AND AFRICA CLINICAL TRIALS SUPPORT SERVICES MARKET, COUNTRY
OUTLOOK, 2021 & 2028 (IN %)
FIGURE
44: UNITED ARAB EMIRATES CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028 (IN
$ MILLION)
FIGURE
45: SAUDI ARABIA CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028 (IN $
MILLION)
FIGURE
46: TURKEY CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028 (IN $ MILLION)
FIGURE
47: SOUTH AFRICA CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028 (IN $
MILLION)
FIGURE
48: REST OF MIDDLE EAST & AFRICA CLINICAL TRIALS SUPPORT SERVICES MARKET
2022-2028 (IN $ MILLION)